Who
Florian Schonharting
Director
Company insider
Files Form 4 as: Director, GH Research; 10% owner, Qlt Inc/bc; Director and 10% owner, Osteologix; 10% owner, Supergen.
In numbers
- Trades disclosed
- 217
- Buys
- 23
- Sells
- 2
- Bought
- $5.8M
- Sold
- $1.3M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 5 Oct 2006
- Last trade
- 8 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 9 Sep 2026 | GHRS GH Researchoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,303 at $0.00 | filing |
| 8 Sep 2026filed 9 Sep 2026 | GHRS GH Researchoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,303 at $0.00 | filing |
| 16 May 2012filed 18 May 2012 | Qlt Inc/bc | SEC FORM 4 Bought | $334K50,000 at $6.67 | filing |
| 11 Jun 2010filed 11 Jun 2010 | Osteologix | SEC FORM 4 Bought | $747K1,494,532 at $0.50 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $68K21,965 at $3.08 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $140K45,300 at $3.09 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $930300 at $3.10 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $44K14,035 at $3.10 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $32K10,224 at $3.11 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $9,8623,161 at $3.12 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $8,6762,772 at $3.13 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $2,727863 at $3.16 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $22K7,087 at $3.17 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $6,9742,193 at $3.18 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $16K4,900 at $3.19 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $3,8401,200 at $3.20 | filing |
| 26 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $3,2001,000 at $3.20 | filing |
| 22 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $84K26,768 at $3.15 | filing |
| 22 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $11K3,350 at $3.16 | filing |
| 22 Apr 2010filed 26 Apr 2010 | Supergen | SEC FORM 4 Sold | $32K10,208 at $3.17 | filing |
News
No headline names them, or the companies they trade most, lately.